A 'chemical help' in middle-ear surgery? A systematic review on sodium 2-mercaptoethanesulfonate.


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 6 7 2021
medline: 10 8 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

Sodium 2-mercaptoethanesulfonate (Mesna) has been proposed as a chemical aid in any surgical procedure, including cholesteatoma surgery. This review investigated the benefits and safety of Mesna during surgical management of cholesteatoma and adhesive otitis media. A systematic literature review was performed to identify clinical studies evaluating topical Mesna application during ear surgery (cholesteatoma or atelectasis). A qualitative analysis based on data extracted was conducted. From 27 articles, 5 retrospective studies were selected for a full analysis for a total of 607 patients (aged 5 to 72 years). Three studies evaluated cholesteatoma recidivism after Mesna application during cholesteatoma surgery, one study evaluated the surgical success rate of Mesna application for the treatment of atelectatic ears and adhesive otitis media, and one study evaluated potential ototoxicity of Mesna during cholesteatoma surgery. All the studies showed overall improvement in recurrence and residual cholesteatoma disease after Mesna application during surgery. Sensorineural hearing loss was not encountered after Mesna application. Mesna application in cholesteatoma surgery could represent a valid and safe support tool during surgical treatment carried out both with microscopy and endoscopy. More studies are required to confirm these promising results.

Identifiants

pubmed: 34219630
doi: 10.1017/S0022215121001535
pii: S0022215121001535
doi:

Substances chimiques

Protective Agents 0
Mesna NR7O1405Q9

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

660-667

Auteurs

A Moffa (A)

Unit of Otolaryngology - Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Unit of Otolaryngology, University of Foggia, Italy.

V Fiore (V)

Unit of Otolaryngology, University of Foggia, Italy.

L Sabatino (L)

Unit of Otolaryngology - Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

M Cassano (M)

Unit of Otolaryngology, University of Foggia, Italy.

M Tarabichi (M)

Department of Otolaryngology, Tarabichi Stammberger Ear Sinus Institute, Dubai, United Arab Emirates.
Department of Otolaryngology, American Hospital Dubai, United Arab Emirates.

M Kapadia (M)

Department of Otolaryngology, Tarabichi Stammberger Ear Sinus Institute, Dubai, United Arab Emirates.

V Rinaldi (V)

Unit of Otolaryngology - Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

M Casale (M)

Unit of Otolaryngology - Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH